Data demonstrates durability of Medtronic's VenaSeal closure system
Medtronic announced the twelve-month results of the VeClose pivotal study, which demonstrated the safety and effectiveness of the VenaSeal(TM) closure system for treatment of incompetent greater saphenous veins with a 96.8 percent closure rate. July 02, 2015